NASDAQ:NUTX

Nutex Health (NUTX) Stock Forecast, Price & News

$0.45

+0.02 (+4.63%)

(As of 06/2/2023 ET)

Compare

Today's Range: $0.42
▼
$0.46
50-Day Range: $0.43
▼
$1.07
52-Week Range: $0.41
▼
$11.15

Volume: 1.97 million shs
Average Volume: 2.24 million shs
Market Capitalization: $294.90 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Nutex Health MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 563.4% Upside
$3.00 Price Target
Short Interest: Healthy
3.41% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.01
Based on 6 Articles This Week
Insider Trading: Acquiring Shares
$314,867 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.03) to ($0.02) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

128th out of 983 stocks

Business Services, Not Elsewhere Classified Industry

26th out of 91 stocks

3.5

Analyst's Opinion

Consensus Rating
Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.00, Nutex Health has a forecasted upside of 563.4% from its current price of $0.45.
Amount of Analyst Coverage
Nutex Health has only been the subject of 1 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
3.41% of the float of Nutex Health has been sold short.
Short Interest Ratio / Days to Cover
Nutex Health has a short interest ratio ("days to cover") of 5.7.
Change versus previous month
Short interest in Nutex Health has recently decreased by 10.28%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Nutex Health does not currently pay a dividend.
Dividend Growth
Nutex Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NUTX.

3.3

News and Social Media Coverage

News Sentiment
Nutex Health has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Nutex Health this week, compared to 1 article on an average week.
Search Interest
Only 16 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.
MarketBeat Follows
5 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nutex Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $314,867.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
48.48% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 1.24% of the stock of Nutex Health is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Nutex Health are expected to grow in the coming year, from ($0.03) to ($0.02) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Nutex Health is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nutex Health is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Nutex Health has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Nutex Health (NASDAQ:NUTX) Stock

Nutex Health, Inc. operates technology-enabled healthcare services. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals and hospital outpatient departments providing comprehensive and high-quality 24/7 care. The Population Health Division establishes and operates independent physician associations and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real State Division includes owning a land and hospital buildings which are leased to the hospital entities The company was founded in 2011 and is headquartered in Houston, TX.

Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

NUTX Stock News Headlines

June 1, 2023 | americanbankingnews.com

Thomas T. Vo Acquires 114,884 Shares of Nutex Health Inc. (NASDAQ:NUTX) Stock

June 1, 2023 | americanbankingnews.com

Thomas T. Vo Purchases 482,088 Shares of Nutex Health Inc. (NASDAQ:NUTX) Stock

June 3, 2023 | Vantage Point (Ad)

We Called (ARWR) In Advance, Which Stocks Are Next?

Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.

May 30, 2023 | benzinga.com

523K Reasons To Be Bullish On Nutex Health Stock

May 25, 2023 | tmcnet.com

MeMed: Nutex Health Announces Agreement with MeMed to Adopt Pioneering MeMed BV® Test Across its Network of 19 sites

May 21, 2023 | americanbankingnews.com

Insider Buying: Nutex Health Inc. (NASDAQ:NUTX) Director Acquires $23,500.00 in Stock

May 20, 2023 | americanbankingnews.com

FY2023 EPS Estimates for Nutex Health Inc. Lifted by Analyst (NASDAQ:NUTX)

May 19, 2023 | msn.com

Why Shares of Nutex Health Jumped on Friday

June 3, 2023 | Behind the Markets (Ad)

"Unknown laser company making HUGE profit from Russia-Ukraine War"

On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>

May 18, 2023 | msn.com

Benchmark Maintains Nutex Health (NUTX) Buy Recommendation

May 16, 2023 | finanznachrichten.de

Nutex Health, Inc.: Nutex Health Reports First Quarter 2023 Financial Results

May 16, 2023 | finance.yahoo.com

NUTEX HEALTH TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

May 15, 2023 | finance.yahoo.com

NUTEX HEALTH REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

May 9, 2023 | americanbankingnews.com

Head to Head Survey: Fiserv (NASDAQ:FISV) and Nutex Health (NASDAQ:NUTX)

May 3, 2023 | finance.yahoo.com

NUTEX HEALTH ANNOUNCES THE OPENING OF ITS FLAGSHIP URGENT CARE CENTER IN SOUTHERN CALIFORNIA

April 24, 2023 | finance.yahoo.com

NUTEX HEALTH ANNOUNCES NATIONAL LEADERSHIP CONFERENCE

April 23, 2023 | americanbankingnews.com

Comparing Nutex Health (NASDAQ:NUTX) and Lyft (NASDAQ:LYFT)

April 19, 2023 | finance.yahoo.com

NUTEX HEALTH PROVIDES UPDATE ON ITS MEDICAL GROUP IN SOUTH FLORIDA

April 19, 2023 | americanbankingnews.com

Nutex Health (NASDAQ:NUTX) Trading 8.9% Higher

April 17, 2023 | finance.yahoo.com

NUTEX HEALTH TO PARTICIPATE IN BTIG'S HIMSS DIGITAL HEALTH IN-PERSON AND VIRTUAL BOOTH TOURS

April 17, 2023 | americanbankingnews.com

Head-To-Head Survey: Nutex Health (NUTX) versus Its Rivals

April 16, 2023 | americanbankingnews.com

Head to Head Review: Nutex Health (NUTX) & Its Peers

April 14, 2023 | uk.finance.yahoo.com

Further weakness as Nutex Health (NASDAQ:NUTX) drops 24% this week, taking one-year losses to 89%

April 12, 2023 | markets.businessinsider.com

Why Nutex Health (NUTX) Shares Are Trading Higher

April 12, 2023 | americanbankingnews.com

Nutex Health (NASDAQ:NUTX) Stock Price Down 4.3%

April 11, 2023 | markets.businessinsider.com

Why Nutex Health Stock Is Surging After Hours

April 11, 2023 | finance.yahoo.com

NUTEX HEALTH ANNOUNCES THAT IT HAS ENTERED INTO A $100 MILLION PRE-PAID ADVANCE AGREEMENT WITH YORKVILLE ADVISORS GLOBAL L.P.

See More Headlines

NUTX Price History

30 days | 90 days | 365 days | Advanced Chart

NUTX Company Calendar

Today: 6/03/2023
Next Earnings (Estimated): 8/28/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Business services, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NUTX
CUSIP: N/A
CIK: 1479681
Web: www.nutexhealth.com
Phone: (713) 660-0557
Fax: 631-670-6780
Employees: 1,150
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.00
High Stock Price Forecast: $3.00
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +563.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.71)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-424,780,000.00
Net Margins: -235.02%
Pretax Margin: -230.28%
Return on Equity: -21.65%
Return on Assets: -9.28%

Debt

Debt-to-Equity Ratio: 2.25
Current Ratio: 1.85
Quick Ratio: 1.78

Sales & Book Value

Annual Sales: $219.29 million
Price / Sales: 1.34
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.17 per share
Price / Book: 2.66

Miscellaneous

Outstanding Shares: 652,140,000
Free Float: 335,985,000
Market Cap: $294.90 million
Optionable: Not Optionable
Beta: 0.68

Key Executives

Thomas T. Vo
Chairman & Chief Executive Officer

Warren Hosseinion
President & Director

C. Denise Pufal
Chief Operating Officer & Operations Director

Jon C. Bates
Chief Financial Officer

Lawrence Schimmel
Chief Medical Information Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NUTX Stock - Frequently Asked Questions

Should I buy or sell Nutex Health stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NUTX shares.
View NUTX analyst ratings or view top-rated stocks.
What is Nutex Health's stock price forecast for 2023?: 2 analysts have issued 12-month price objectives for Nutex Health's stock. Their NUTX share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 563.4% from the stock's current price.
View analysts price targets for NUTX or view top-rated stocks among Wall Street analysts.
How have NUTX shares performed in 2023?: Nutex Health's stock was trading at $1.90 at the beginning of the year. Since then, NUTX shares have decreased by 76.2% and is now trading at $0.4522.
View the best growth stocks for 2023 here.
When is Nutex Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, August 28th 2023.
View our NUTX earnings forecast.
What is Nutex Health's stock symbol?: Nutex Health trades on the NASDAQ under the ticker symbol "NUTX."

Who are Nutex Health's major shareholders?: Nutex Health's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.83%), State Street Corp (0.63%), Geode Capital Management LLC (0.43%), Swiss National Bank (0.11%), Credit Suisse AG (0.04%) and Balyasny Asset Management L.P. (0.03%). Insiders that own company stock include John J Waters and Thomas T Vo.
View institutional ownership trends.
How do I buy shares of Nutex Health?: Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Nutex Health's stock price today?: One share of NUTX stock can currently be purchased for approximately $0.45.
How much money does Nutex Health make?: Nutex Health (NASDAQ:NUTX) has a market capitalization of $294.90 million and generates $219.29 million in revenue each year. The company earns $-424,780,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis.
How many employees does Nutex Health have?: The company employs 1,150 workers across the globe.
How can I contact Nutex Health?: Nutex Health's mailing address is 2455 EAST SUNRISE BLVD. SUITE 1204, FORT LAUDERDALE FL, 33304. The official website for the company is www.nutexhealth.com. The company can be reached via phone at (713) 660-0557, via email at investors@nutexhealth.com, or via fax at 631-670-6780.

This page (NASDAQ:NUTX) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial